Sustainability of Community-Based Specialized Mental Health Services in Five European Countries: Protocol for Five Randomized Controlled Trial-Based Health-Economic Evaluations Embedded in the RECOVER-E Program.
community-based mental health care
cost-effectiveness analysis
cost-utility analysis
economic evaluation
mental health
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
received:
13
12
2019
accepted:
21
03
2020
revised:
06
03
2020
entrez:
2
6
2020
pubmed:
2
6
2020
medline:
2
6
2020
Statut:
epublish
Résumé
Community-based recovery-oriented mental health services for people with severe mental disorders have not been fully implemented in Bulgaria, Croatia, Macedonia, Montenegro, and Romania. The RECOVER-E project facilitates the implementation of specialized mental health care delivered by setting up services, implementing the services, and evaluating multidisciplinary community mental health teams. The outcomes of the RECOVER-E project are assessed in a trial-based outcome evaluation in each of the participating countries with a health-economic evaluation linked to these trials. The aim of this protocol paper is to describe the methodology that will be used for the health-economic evaluation alongside the trials. Implementation sites have been selected in each of the five countries where hospital-based mental health services are available (care as usual [CAU]) for patients with severe mental disorders (severe depression, bipolar disorder, schizophrenia, and other psychotic disorders). The newly implemented health care system will involve community-based recovery-oriented mental health care (CMHC). At each site, 180 consenting patients will be randomized to either CAU or CMHC. Patient-level outcomes are personal and social functioning and quality-adjusted life years (QALYs). Data on participants' health care use will be collected and corresponding health care costs will be computed. This enables evaluation of health care costs of CMHC as compared with CAU, and these costs can be related to patient-level outcomes (functioning and QALY gains) in health-economic evaluation. Data collection was started in December 2018 (Croatia), February 2019 (Montenegro), April 2019 (Romania), June 2019 (North Macedonia), and October 2019 (Bulgaria). The findings of the outcome evaluations will be reported for each of the five countries separately, and the five trials will be pooled for multilevel analysis on a combined dataset. The results of the health-economic evaluation of the RECOVER-E project will contribute to the growing evidence base on the health and economic benefits of recovery-oriented and community-based service models for health systems in transition. (1) ClinicalTrials.gov NCT03922425 (Bulgaria); https://clinicaltrials.gov/ct2/show/NCT03922425 (2) ClinicalTrials.gov NCT03862209 (Croatia); https://clinicaltrials.gov/ct2/show/NCT03862209 (3) ClinicalTrials.gov NCT03892473 (Macedonia); https://clinicaltrials.gov/ct2/show/NCT03892473 (4) ClinicalTrials.gov NCT03837340 (Montenegro); https://clinicaltrials.gov/ct2/show/NCT03837340 (5) ClinicalTrials.gov NCT03884933 (Romania); https://clinicaltrials.gov/ct2/show/NCT03884933. DERR1-10.2196/17454.
Sections du résumé
BACKGROUND
BACKGROUND
Community-based recovery-oriented mental health services for people with severe mental disorders have not been fully implemented in Bulgaria, Croatia, Macedonia, Montenegro, and Romania. The RECOVER-E project facilitates the implementation of specialized mental health care delivered by setting up services, implementing the services, and evaluating multidisciplinary community mental health teams. The outcomes of the RECOVER-E project are assessed in a trial-based outcome evaluation in each of the participating countries with a health-economic evaluation linked to these trials.
OBJECTIVE
OBJECTIVE
The aim of this protocol paper is to describe the methodology that will be used for the health-economic evaluation alongside the trials.
METHODS
METHODS
Implementation sites have been selected in each of the five countries where hospital-based mental health services are available (care as usual [CAU]) for patients with severe mental disorders (severe depression, bipolar disorder, schizophrenia, and other psychotic disorders). The newly implemented health care system will involve community-based recovery-oriented mental health care (CMHC). At each site, 180 consenting patients will be randomized to either CAU or CMHC. Patient-level outcomes are personal and social functioning and quality-adjusted life years (QALYs). Data on participants' health care use will be collected and corresponding health care costs will be computed. This enables evaluation of health care costs of CMHC as compared with CAU, and these costs can be related to patient-level outcomes (functioning and QALY gains) in health-economic evaluation.
RESULTS
RESULTS
Data collection was started in December 2018 (Croatia), February 2019 (Montenegro), April 2019 (Romania), June 2019 (North Macedonia), and October 2019 (Bulgaria). The findings of the outcome evaluations will be reported for each of the five countries separately, and the five trials will be pooled for multilevel analysis on a combined dataset.
CONCLUSIONS
CONCLUSIONS
The results of the health-economic evaluation of the RECOVER-E project will contribute to the growing evidence base on the health and economic benefits of recovery-oriented and community-based service models for health systems in transition.
TRIAL REGISTRATION
BACKGROUND
(1) ClinicalTrials.gov NCT03922425 (Bulgaria); https://clinicaltrials.gov/ct2/show/NCT03922425 (2) ClinicalTrials.gov NCT03862209 (Croatia); https://clinicaltrials.gov/ct2/show/NCT03862209 (3) ClinicalTrials.gov NCT03892473 (Macedonia); https://clinicaltrials.gov/ct2/show/NCT03892473 (4) ClinicalTrials.gov NCT03837340 (Montenegro); https://clinicaltrials.gov/ct2/show/NCT03837340 (5) ClinicalTrials.gov NCT03884933 (Romania); https://clinicaltrials.gov/ct2/show/NCT03884933.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
DERR1-10.2196/17454.
Identifiants
pubmed: 32476658
pii: v9i6e17454
doi: 10.2196/17454
pmc: PMC7296406
doi:
Banques de données
ClinicalTrials.gov
['NCT03884933', 'NCT03892473', 'NCT03922425', 'NCT03837340', 'NCT03862209']
Types de publication
Journal Article
Langues
eng
Pagination
e17454Informations de copyright
©Ben F M Wijnen, Filip Smit, Ana Ivičević Uhernik, Ana Istvanovic, Jovo Dedovic, Roumyana Dinolova, Raluca Nica, Robert Velickovski, Michel Wensing, Ionela Petrea, Laura Shields-Zeeman. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 01.06.2020.
Références
Stat Med. 2019 Jan 30;38(2):210-220
pubmed: 30207407
Cost Eff Resour Alloc. 2013 Mar 25;11(1):6
pubmed: 23531194
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
Appl Health Econ Health Policy. 2005;4(2):65-75
pubmed: 16162026
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
Community Ment Health J. 2007 Aug;43(4):421-33
pubmed: 17514502
Dialogues Clin Neurosci. 2011;13(2):217-24
pubmed: 21842619
Health Qual Life Outcomes. 2010 May 19;8:51
pubmed: 20482853
Int J Technol Assess Health Care. 2020 Apr;36(2):72-74
pubmed: 32000868
J Health Econ. 1995 Jun;14(2):171-89
pubmed: 10154656
Eur J Health Econ. 2003 Sep;4(3):222-31
pubmed: 15609189
BMC Psychiatry. 2008 Dec 04;8:93
pubmed: 19055813
Can J Psychiatry. 1999 Jun;44(5):455-63
pubmed: 10389606
Pharmacoeconomics. 2015 Nov;33(11):1137-54
pubmed: 26040242
Stat Med. 2010 Dec 10;29(28):2920-31
pubmed: 20842622